346
Notes
Chem. Pharm. Bull. 51(3) 346—350 (2003)
Vol. 51, No. 3
Characterization of Hydrazine Derivative: Proposed Decomposition
Mechanism and Structure Elucidation of Decomposition Compounds
Takayuki NEMOTO,* Eliada LAZOURA, and Takashi NOMOTO
Process R & D, Laboratories for Technology Development, Banyu Pharmaceutical Co., Ltd.; 3–9–1 Kamimutsuna,
Okazaki, Aichi 444–0858, Japan.
Received November 8, 2002; accepted December 16, 2002; published online December 16, 2002
Decomposition of protected hydrazine diol (1) hemi-oxalate, a key intermediate of the potent indolocar-
bazole-based DNA topoisomerase I inhibitor (2), was investigated. Spectroscopic analysis revealed that the main
decomposition compounds of the hydrazine derivative were a peroxide (3) and an alcohol derivative (4). The per-
oxide derivative (3) was proposed to form in the presence of oxygen- and/or H2O-generated radicals, which was
subsequently reduced to the more stable alcohol derivative (4). A plausible decomposition mechanism was pro-
posed and our findings were substantiated by chemical conversion.
Key words hydrazine; radical; decomposition; peroxide; DNA topoisomerase I
CH3CN/0.1% H3PO4 (10/90) to CH3CN/0.1% H3PO4 (50/50) over 40 min,
then to CH3CN/0.1% H3PO4 (90/10) over 20 min and maintained at these
conditions for a further 5 min, flow rate 1.0 ml/min. Absorbance was de-
tected at 220 nm.
Preparative HPLC The HPLC equipment was as follows : an octadecyl
silica (ODS) column [Shim-pack PREP-ODS(H) KIT, 250ϫ20 mm i.d.] and
Shimadzu VP Series HPLC. Gradient elution was performed from
CH3CN/H2O (10/90) to CH3CN/H2O (50/50) over 40 min, then to
CH3CN/H2O (90/10) over 20 min and maintained at these conditions for a
further 5 min, flow rate 10.0 ml/min. Absorbance was detected at 220 nm.
Pure 3 (tRϭ56.7 min), and 4 (tRϭ54.0 min) were collected for further analy-
sis. While 4 was freeze dried, 3 was extracted from H2O using benzene to
avoid decomposition.
DNA topoisomerase I (topo I), presently represents an at-
tractive target for the development of inhibitors for use as
anti-bacterial, anti-fungal, and anti-cancer chemotherapeutic
agents. Recently our group reported the practical synthesis of
a potent indolocarbazole-based topo I inhibitor (2), produced
by coupling the glucoside (5) and protected hydrazine diol
(1) hemi-oxalate (Chart 1).1) Often, however, unexpected ob-
stacles are encountered in a scale-up synthesis. In this case,
the decomposition of a key intermediate, protected hydrazine
diol (1) hemi-oxalate, posed problems.
Hydrazine derivatives are known to easily decompose in
the presence of radicals.2,3) Commonly used as rocket fuels,
most of them are endothermic compounds.3) Upon storage,
protected hydrazine diol (1) hemi-oxalate was found to de-
LC/MS Spectrometry (MS) MS spectra were recorded on a JEOL
JMS-LC mate and/or a Finnigan Thermoquest Model LC-Q mass spectrom-
eter coupled to an Agilent 1100 Series HPLC. An ODS column (YMC AM-
303, 250ϫ4.6 mm i.d.) was used, with gradient condition from CH3CN/
compose, even when kept in the dark at 5 °C and under nitro- 0.04% HCOOH (10/90) to CH3CN/0.04% HCOOH (50/50) over 30 min and
subsequently to CH3CN/0.04% HCOOH (90/10) for a further 30 min, flow
rate 1.0 ml/min (0.2 ml/min split to LC-MS). Absorbance was detected at
220 nm. Mass spectra were recorded in positive electrospray ionization
(ESIϩ) mode.
gen.
Here we reports the decomposition of protected hydrazine
diol (1) hemi-oxalate, structure elucidation of the decompo-
sition compounds and propose a plausible decomposition
mechanism.
NMR Spectrometry (NMR) NMR spectra were recorded on a Bruker
DRX500 (500 MHz). NMR chemical shifts are reported as d values in ppm
relative to TMS. For LC-NMR of the peroxide derivative 3, an Agilent 1100
Series HPLC was coupled to the NMR spectrometer. An ODS column
(YMC AM-303, 250ϫ4.6 mm i.d.) was used, with gradient condition from
CD3CN/D2O (10/90) to CD3CN/D2O (50/50) in 5 min, then to CD3CN/D2O
(90/10) for 30 min, and maintained at these conditions for a further 5 min,
Experimental
Materials All compounds were prepared by Banyu Pharmaceutical Co.
Ltd. (Okazaki, Japan). The purity of protected hydrazine diol (1) hemi-ox-
alate was above 99.9% at the time of storage, in the dark and under nitrogen
at 5 °C for 6 months in a polyethylene bag stored in a steel drum. All chemi-
cals and solvent were of analytical reagent grade.
flow rate 1.0 ml/min. Absorbance was detected at 220 nm. Pure
3
(tRϭ17.7 min) was collected for further online analysis.
Analytical HPLC The HPLC equipment was as follows : an octyl silica
(C8) column (Waters Symmetry C8, 250ϫ4.6 mm i.d.), Waters 2695 separa-
tion module coupled to a Waters 2487 dual l absorbance detector and a Wa-
ters 2996 photodiode array detector. Gradient elution was performed from
Results and Discussion
Structure Elucidation of Decomposition Compounds
The HPLC profile of decomposed protected hydrazine diol
(1) hemi-oxalate is shown in Fig. 1. Initial purity was over
99.9%, however, after storage at 5 °C for 6 months under ni-
trogen in a polyethylene bag and inside a steel drum, the pu-
rity decreased to 95.9 % with impurity levels ranging be-
tween 0.01—0.96% (Fig. 2). The following decomposition
compounds were detected (Fig. 3): a secondary amine (6)
[m/z 272 (MϩH)ϩ; 0.11%], formed by homolytical cleavage
of the N–N bond by HO ; 1-benzyloxy-3-benzoyloxy-2-
hydrazinopropane (7) [m/z 301 (MϩH)ϩ; 0.06%], formed by
oxidation of one of the benzyl oxy groups; and the dimer
compound (8) [m/z 539 (MϩH)ϩ; 0.27%], formed by cou-
pling 1 to 1,3-dibenzyloxyketone (9), formed by oxidation of
2,3)
·
Chart 1. Synthesis of Indolocarbazole Compound (2)
* To whom correspondence should be addressed. e-mail: nemototy@banyu.co.jp
© 2003 Pharmaceutical Society of Japan